This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Forschungsverbund Berlin E.v.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Hassane Belabed
Introduction
Hassane Belabed is an accomplished inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific signaling pathways in the body. His work is particularly relevant for treating various medical conditions.
Latest Patents
Hassane Belabed holds a patent for "Heterocyclic compounds as class II phosphoinositide 3-kinase inhibitors." This patent describes compounds that can inhibit class II phosphoinositide 3-kinase (PI3K) signaling. These compounds are useful for treating medical conditions associated with defective PI3K signaling, such as myopathy, cancer, diabetes, thrombosis, or cardiovascular disease. He has 1 patent to his name.
Career Highlights
Belabed is currently associated with Forschungsverbund Berlin E.V., where he continues to advance his research in the field of pharmacology. His innovative approach to drug development has garnered attention in the scientific community.
Collaborations
Throughout his career, Hassane has collaborated with notable colleagues, including Wen-Ting Lo and Volker Haucke. These partnerships have enriched his research and contributed to the advancement of their shared goals in medicinal chemistry.
Conclusion
Hassane Belabed's work exemplifies the impact of innovative research in medicine. His contributions to the development of PI3K inhibitors highlight the importance of targeted therapies in treating complex medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile